The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...

The U.S. Food and Drug Administration is preparing to speed up approvals for biosimilars, or generic versions of complex ...

Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary ...

Health Secretary Robert F. Kennedy Jr. and Medicare Administrator Dr. Mehmet Oz are scheduled to hold a news briefing ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

The U.S. Food and Drug Administration has flagged three of Philips' medical device facilities after inspections found they ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The Food and Drug Administration is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to ...

The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...

Food and Drug Administration on Wednesday said it is aiming to reduce the number of human clinical studies required for ...